Facial Dermatoses

Skin diseases involving the FACE.

Also Known As:

Facial Dermatosis; Nodular Elastosis; Dermatoses, Facial; Dermatosis, Facial; Elastoidoses, Nodular; Elastoidosis, Nodular; Elastoses, Nodular; Elastosis, Nodular; Favre Racouchot Syndrome; Nodular Elastoidoses; Nodular Elastoses; Syndrome, Favre-Racouchot; Favre-Racouchot Syndrome; Nodular Elastoidosis

Networked: 44 relevant articles (4 outcomes, 9 trials/studies)

Relationship Network

Disease Context: Research Results

Skin and Connective Tissue Diseases
- Skin Diseases: 13127
  - Facial Dermatoses: 44

Related Diseases

1.	Rosacea (Acne Rosacea)
2.	Pigmentation Disorders (Ito Syndrome)
3.	Eczema
4.	Cicatrix (Scar)
5.	Contact Dermatitis (Eczema, Contact)

Experts

1.	Draelos, Zoe Diana: 2 articles (11/2014 - 03/2010)
2.	Bari, Arfan Ul: 2 articles (04/2007 - 03/2005)
3.	Iqbal, Zafar: 2 articles (04/2007 - 03/2005)
4.	Rahman, Simeen Ber: 2 articles (04/2007 - 03/2005)
5.	Giacalone, Serena: 1 article (01/2022)
6.	Nazzaro, Gianluca: 1 article (01/2022)
7.	Spigariolo, Cristina Beatrice: 1 article (01/2022)
8.	Chiara, Airoldi: 1 article (01/2022)
9.	Edoardo, Cammarata: 1 article (01/2022)
10.	Elia, Esposto: 1 article (01/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Facial Dermatoses:

1.	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 04/01/2007 - "Chemical peeling with salicylic acid is an effective and safe treatment modality in many superficial facial dermatoses." 03/01/2005 - "The present study is directed towards safety concerns associated with superficial chemical peeling with salicylic acid in various facial dermatoses. " 03/01/2019 - "On the basis of our results, we suggest an alternative therapeutic approach with salicylic acid peels followed by mechanical comedo extraction in patients suffering from Favre-Racouchot syndrome." 03/01/2019 - "Combination of 30% Salicylic Acid Peels and Mechanical Comedo Extraction for the Treatment of Favre-Racouchot Syndrome." 04/01/2007 - "Superficial chemical peeling with salicylic Acid in facial dermatoses."
2.	SulfurIBA 08/01/2015 - "Sodium sulfacetamide is effective in the management of a variety of inflammatory facial dermatoses and often is used in combination with sulfur for a synergistic effect. " 03/01/2010 - "The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses."
3.	Sulfacetamide (Bleph)FDA LinkGeneric 08/01/2015 - "Sodium sulfacetamide is effective in the management of a variety of inflammatory facial dermatoses and often is used in combination with sulfur for a synergistic effect. " 03/01/2010 - "The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses."
4.	SodiumIBA 08/01/2015 - "Sodium sulfacetamide is effective in the management of a variety of inflammatory facial dermatoses and often is used in combination with sulfur for a synergistic effect. " 03/01/2010 - "The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses."
5.	SteroidsIBA 03/01/2020 - "A total of 316 patients (53 males, 263 females) presented with topical steroid-induced facial dermatoses during the entire study period. " 03/01/2020 - "Study of Clinical Profile of Patients Presenting with Topical Steroid-Induced Facial Dermatosis to a Tertiary Care Hospital." 01/01/2011 - "Majority of patients were using potent (class II) topical steroids for trivial facial dermatoses. " 09/01/2023 - "Our findings showed that cosmetic physicians in the Republic of Korea have used PN as a part of combination treatment for facial erythema resulting from inflammatory facial dermatosis and repeated laser/ microneedle radiofrequency, rather than from steroid overuse. " 09/01/2023 - "Polynucleotides were used by 84.4%, 66.4%, and 47.4% of physicians for facial erythema caused by inflammatory facial dermatosis, repeated laser/microneedle radiofrequency, and steroid overuse, respectively. "
6.	Irritants (Vesicants)IBA 04/01/2021 - "Comparing quarantine and after quarantine periods, no statistically significant differences were found for CE-approved masks, whilst differences were detected in non-CE-approved masks regarding incidence of facial dermatoses (P<0.0001)and irritant contact dermatitis (P=0.0041). " 04/01/2021 - "Remarkably, non-CE-approved masks resulted in patients displaying a statistically significant higher incidence of facial dermatoses and irritant contact dermatitis compared to CE-approved masks, and these differences were mainly driven by non-PPE non-SM masks. " 01/01/1994 - "Irritant plant dermatoses (2.5%), episodes of acute systemic intoxication from pesticides (6.8%), onychopathies due to chronic trauma (16%), contact dermatitis of the hands (12%), chilblains (7%) and Favre-Racouchot syndrome (2.5%) showed a higher prevalence in the study group. " 09/01/2020 - "COVID-19 (SARS-COV-2) pandemic is associated with aggravation of facial dermatoses caused by professional prophylactic measures, mostly face masks, especially reported in healthcare workers, such as irritant and contact dermatitis, seborrheic dermatitis, rosacea, acne. "
7.	Adrenal Cortex Hormones (Corticosteroids)IBA 03/31/2017 - "A total of 200 patients with facial dermatoses and topical corticosteroid misapplication daily over face for not less than 30 days were included in the study. " 01/01/2020 - "A total of 235 patients with facial dermatoses secondary to the application of topical corticosteroids and counterfeit products or, a mixed formulation, for cosmetic purposes were recruited. " 10/01/2012 - "The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream."
8.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/01/2000 - "The aim of this study was to look at a possible relationship between the recurrent perimenstrual dermatosis - facial Herpes simplex infection and the serum concentrations of interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-alpha). "
9.	Interleukin-2 (IL2)IBA 09/01/2000 - "The aim of this study was to look at a possible relationship between the recurrent perimenstrual dermatosis - facial Herpes simplex infection and the serum concentrations of interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-alpha). "
10.	Immunoglobulins (Immunoglobulin)IBA 09/01/1974 - "Immunoglobulin and complement deposits in the skin in inflammatory facial dermatoses--an immunofluorescence study."

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 08/01/2023 - "This study included 53 patients who benefited from a therapeutic make-up consultation in the context of various facial dermatoses (pigmentation disorders, scars, acne, rosacea, eczema, adverse events of chemotherapy, etc.). "
2.	Dye Lasers 01/01/2008 - "Efficacy of pulsed dye laser in cosmetically distressing facial dermatoses in skin types IV and V."
3.	Therapeutics 01/26/2022 - "The aim of this paper is to discuss the pathogenesis, address clinicians on the correct differential diagnoses among facial dermatoses, and move towards the correct therapy." 02/15/1981 - "[A new dermato-surgical therapy for the Favre-Racouchot syndrome (author's transl)]." 03/01/1983 - "A 56-year-old woman developed Favre-Racouchot syndrome involving her face and scalp primarily at the sites of x-ray irradiation for therapy of an astrocytoma. " 04/01/2007 - "The cases show that the calcineurin antagonist pimecrolimus offers an effective and well-tolerated therapy option in the acute therapy of steroid-aggravated facial dermatoses."
4.	Gas Lasers 01/01/2023 - "Treatment of severe Favre-Racouchot Syndrome with carbon dioxide laser." 03/01/2014 - "Favre-Racouchot syndrome: a novel two-step treatment approach using the carbon dioxide laser." 01/01/2010 - "Combined treatment of Favre-Racouchot syndrome with a superpulsed carbon dioxide laser: report of 50 cases."
5.	Skin Care 11/01/2014 - "Facial skin care products and cosmetics can both aid or incite facial dermatoses. " 08/01/2011 - "Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach."